Blogs

Genzyme Stockholders Vote on Drug Manufacturing's Strategic Importance

Notes from BIO 2009: Irish Pharma--Can Innovation and Quality Trump Cost and Infrastructure Considerations?

Gephardt, AZ’s Brennan on Innovation: What Is Our Moon Shot?

Will Chemical Engineers Save Pharma?

A Contrarian View of FDA: Bloated and Inefficient

Russ Somma on QbD - "How Did You Launch Before, With a Catapult?"

What Does Lilly and Covance R&D Deal Mean for Industry?

Research and The Internet: Is the Tail Getting Too Short?